08.15.25 -- The Safety Potential Of Conditionally Active Biologics

Understanding the complex effects of inflation, recession, and regulatory shifts is key to navigating the challenges faced by the biopharmaceutical manufacturing sector and ensuring its continued growth.

The revised GMP Annex 1 guidelines emphasize quality risk management, enhanced environmental monitoring, and data integrity, which aim to minimize contamination and ensure patient safety.

In your pursuit of developing a high-quality biosimilar, think strategically. Consider what type of biologic your team’s expertise can support and which is needed most in your target market.

Navigate the complexities of PUPSIT with expert guidance. Discover best practices for assembly design, regulatory compliance, and troubleshooting common challenges in sterile filtration environments.

Through case studies and practical insights spanning complex drug substance and drug products like ADCs, learn more about navigating complexities with integrated regulatory services and strategic guidance.

Three studies focus on a product designed to address unmet needs in subcutaneous drug therapies for chronic diseases, including sterilization methods and a Human Factors evaluation.

Learn how site-specific fluorescent labeling addresses key challenges in flow cytometry-based evaluations by enhancing assay sensitivity, reducing variability, and ensuring reliable results.

Discover how precise flow cytometric identification of CAR+ cells across diverse models and workflows enables high specificity, flexibility, and sensitivity—even in rare or low-expression populations.

Achieving desired glycosylation for therapeutic proteins can be difficult. Explore innovative approaches to optimize this critical quality attribute.

Discover the advantages of MMS over CD spectroscopy for analyzing protein higher-order structures. See how MMS accurately identifies subtle changes crucial for understanding protein function.

Explore how Pharma 4.0 and digital validation are revolutionizing manufacturing by driving efficiency, ensuring quality, and enabling a Zero Defect paradigm through continuous improvement.

Future-proof your pharma manufacturing. Discover why manual visual inspection remains foundational and how advanced software can build a high-fidelity baseline for automation success.

Ensure cleanroom air quality with optical particle counters. Explore how OPCs work, their performance metrics, and key considerations for choosing the right one.

Effective procedure development starts with understanding the purpose and should integrate change management, risk management, and knowledge management to ensure a robust quality system.

Dive into a summary of stability considerations and process examples for recombinant proteins, mAbs, gene therapy, and subunit vaccines.

Explore how molecular-based technologies, including PCR and Next Generation Sequencing, are transforming viral safety testing by offering broader, more effective alternatives to traditional animal-based methods like in vivo assays.

Electroporation enables genetic research by introducing material into cells, advancing disease modeling, gene therapy, and ion channel studies.

Column temperature critically affects the reversed-phase separation of fatty acid-modified GLP-1 RAs and impurities. Learn how precise control enhances resolution and reproducibility.